RepliCel Life Sciences

RP-X

CVE:RP

0.25
0.00 (0.00%)
RepliCel Life Sciences is a Canadian regenerative medicine company based in Vancouver, British Columbia. The company focuses on development of cell therapies using a patient's own cells.
More at Wikipedia

Analysis and Opinions about RP-X

Signal
Opinion
Expert
BUY
BUY
October 21, 2014

Life sciences. Have an interesting regenerative technology. For example, they can take a hair follicle and extract certain cells, and then replicate them 1 million times and then re-inject them back in areas where they are needed. It is very, very rare to have a company this small with 2 products in phase 2 trials. Feels phase 2 is when life science companies add the most value. Next year they will have a 3rd, which is very rare for a company. Thinks they will put the company up for sale next year, and it will become a bidding war.

Life sciences. Have an interesting regenerative technology. For example, they can take a hair follicle and extract certain cells, and then replicate them 1 million times and then re-inject them back in areas where they are needed. It is very, very rare to have a company this small with 2 products in phase 2 trials. Feels phase 2 is when life science companies add the most value. Next year they will have a 3rd, which is very rare for a company. Thinks they will put the company up for sale next year, and it will become a bidding war.

Jerome Hass
Portfolio Manager, Lightwater Partners
Price
$0.440
Owned
Yes
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »